Information on Coronavirus (COVID-19)

Your health and well-being is our highest priority. As we welcome you back to services, please continue to stay informed with Doylestown Health's response to COVID-19. Learn more

Welcome Back: A message from Doylestown Health's President and CEO, Jim Brexler

We've established several new precautions to protect the health of our patients and staff. Hear from our President and CEO, Jim Brexler, and learn about the additional steps we've taken to keep you safe. Learn more

Clinical Trials

Microscope with laboratory glassware

Gastroenterology Clinical Trials

Doylestown Health's gastroenterology team participates in clinical trials and research to help shape the way gastrointestinal disease is treated.

Active Trials: Open to Enrollment

Non-alcoholic Stearotic Hepatitis (NASH, fatty liver) - REGENERATE (NASH)

  • Evaluating the impact on NASH with fibrosis of obeticholic acid treatment
  • Coordinated by the Doylestown Health Medical Research Department: 215.345.2119

Active Trials: Not Accepting New Patients

Moderate to severe Ulcerative Colitis - UNIFI

  • Evaluating the safety and efficacy of ustekinumab induction and maintenance therapy in participants with moderately to severely active ulcerative colitis
  • Enrolled patients in follow up through February 2020

For more information about Doylestown Health's open trials, visit the U.S. National Institutes of Health's Clinical Trials database.

Blog Posts

View All Articles

Upcoming Classes and Events

Find a doctor or request an appointment.